The Net Margin of Intra-Cellular Therapies Inc (ITCI) is -10.97%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -10.97% |
| 2023-12-31 | -30.08% |
| 2022-12-31 | -102.40% |
| 2021-12-31 | -339.02% |
| 2020-12-31 | -995.61% |
| 2019-12-31 | -147700.00% |
| 2018-12-31 | -48900.00% |
| 2017-12-31 | -38800.00% |
| 2016-12-31 | -104800.00% |